Attitudes of patients and mental health staff to antipsychotic long-acting injections: Systematic review

British Journal of Psychiatry

Volumn 195, Issue SUPPL. 52, 2009, Pages

  Waddell, Linda ^a   Taylor, Mark ^b  

^a Hairmyres Hospital   (United Kingdom)

^b Ballenden House   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

DRUG TOLERABILITY; HUMAN; INJECTION; MAINTENANCE THERAPY; MEDICAL STAFF; MENTAL HEALTH; PATIENT ATTITUDE; PATIENT AUTONOMY; PATIENT COMPLIANCE; PATIENT EDUCATION; PSYCHIATRIST; RELAPSE; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; STAFF TRAINING; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; ATTITUDE TO HEALTH; DELAYED RELEASE FORMULATION; HEALTH PERSONNEL ATTITUDE; PSYCHOSIS;

ANTIPSYCHOTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; DELAYED-ACTION PREPARATIONS; HUMANS; INJECTIONS; MEDICATION ADHERENCE; PSYCHOTIC DISORDERS;

EID: 71249115194     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.195.52.s43     Document Type: Review

References (37)

1. Walburn J, Gray R, Gournay K, Quraishi S, David A. Systematic review of patients and nurse attitudes to depot antipsychotic medication. Br J Psychiatry 2001; 179: 300-307 (Pubitemid 32996038)
2. Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999; 56: 241-247 (Pubitemid 29125132)
3. Zygmunt A, Olfson M, Boyer CA, Mechanic D. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry 2002; 159: 1653-1664
4. Davis JM, Chen N. Choice of maintenance medication for schizophrenia. J Clin Psychiatry 2003; 64: 24-33.
5. Mahadun PN, Marshall M. Insight and treatment attitude in schizophrenia: comparison of patients on depot and atypical antipsychotics. Psychiatr Bull 2008; 32: 53-56 (Pubitemid 351278706)
6. Chue P, Emsley R. Long-acting formulations of atypical antipsychotics. Time to reconsider when to introduce depot antipsychotics. CNS Drugs 2007; 21: 441-448
7. University of York NHS Centre for Reviews and Dissemination. CRD Report 4: Undertaking Systematic Reviews of Research on Effectiveness (http://www.york.ac.uk/inst/crd/report4.htm).
8. Patel MX, De Zoysa N, Bernadt M, David A. Depot and oral antipsychotics: patient preferences and attitudes are not the same thing. J Psychopharmacol 2009; 23: 789-796
9. Patel MX, De Zoysa N, Bernadt M, David AS. A cross-sectional study of patients' perspectives on adherence to antipsychotic medication: depot versus oral. J Clin Psychiatry 2008; 69: 1548-1556
10. Bradstreet S, Norris R. All You Need to Know? Scottish Survey of People's Experience of Psychiatric Drugs. Scottish Association for Mental Health, 2004 (http://www.samh.org.uk/assets/files/75.pdf).
11. Castle D, Morgan V, Jablensky A. Antipsychotic use in Australia: the patients' perspective. Aust N Z J Psychiatry 2002; 36: 633-641 (Pubitemid 35174403)
12. Heres S, Schmitz FS, Leucht S, Pajonk FG. The attitude of patients towards antipsychotic depot treatment. Int Clin Psychopharmacol 2007; 22: 275-282 (Pubitemid 47237546)
13. Patel MX, Nikolaou V, David AS. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia. Psychol Med 2003; 33: 83-89 (Pubitemid 36113403)
14. Patel MX, De zoysa N, Baker D, David AS. Antipsychotic depot medication and attitudes of community psychiatric nurses. J Psychiatr Ment Health Nurs 2005; 12: 237-244
15. Patel MX, Yeung FKK, Haddad PM, David AS. Psychiatric nurses' attitudes to antipsychotic depots in Hong Kong and comparison with London. J Psychiatr Ment Health Nurs 2008; 15: 758-766
16. Patel MX, Haddad PM, Chaudhry IB, McLoughlin S, Husain N, David AS. Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years. J Psychopharmacol 2009; May 28 [Epub ahead of print].
17. Lambert T, Brennan A, Castle D, Kelly DL, Conley RR. Perception of depot antipsychotics by mental health professionals. J Psychiatr Pract 2003; 9: 252-260 (Pubitemid 36741439)
18. Heres S, Hamann J, Kissling W, Leucht S. Attitudes of psychiatrists toward antipsychotic depot medication. J Clin Psychiatry 2006; 67: 1948-1953 (Pubitemid 46048193)
19. Harris N, Lovell K, Day JC. Mental health practitioner's attitude towards maintenance neuroleptic treatment for people with schizophrenia. J Psychiatr Ment Health Nurs 2007; 14: 113-119
20. Angermeyer MC, Boitz K, Loffler W, Muller P, Priebe S. Attitude of family to clozapine. Psychiatr Prax 1999; 26: 181-187
21. Angermeyer MC, Matschinger H. Attitude of family to neuroleptics. Psychiatr Prax 1999; 26: 171-174
22. Kanazawa T, Tsutsumi A, Kawashige S, Nishimoto Y, Yoneda H. The questionnaire of the usage of depot injection in Japan. Eur Neuropsychopharmacol 2008; 18 (suppl 4): S418.
23. Haddad PM, Taylor M, Niaz OS. First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies. Br J Psychiatry 2009; 195 (suppl 52): S20-8.
24. Samele C, Lawton-Smith S, Warner L, Mariathasan J. Patient choice in psychiatry. Br J Psychiatry 2007; 191: 1-2.
25. Department of Health. Creating a Patient-Led NHS: Delivering the NHS Improvement Plan. Department of Health, 2005.
26. Balon R. The underutilization of depot neuroleptic therapy. J Clin Psychiatry 1994; 55: 39.
27. Pereira S, Pinto R. A survey of the attitudes of chronic psychiatric patients living in the community toward their medication. Acta Psychiatr Scand 1997; 95: 464-468 (Pubitemid 27272195)
28. Roberts LW, Geppert CMA. Ethical use of long-acting medications in the treatment of severe and persistent mental illnesses. Compr Psychiatry 2004; 45: 161-167
29. Muir-Cochrane E. The case management practices of community mental health nurses: doing the best we can. Aust N Z J Ment Health 2001; 10: 210-220
30. Gray R, Parr AM, Plummer S. A national survey of practice nurse involvement in mental health interventions. J Adv Nurs 1999; 30: 901-906
31. Basu A, McIvor RJ. service innovations: from depot clinic to medication review service - developing an evidence-based service within a community mental health team. Psychiatr Bull 2007; 31: 19-21. (Pubitemid 46099173)
32. Waddell L, Taylor M. A new self-rating scale for detecting atypical or second-generation antipsychotic side effects. J Psychopharmacol 2008; 22: 238-243 (Pubitemid 351847452)
33. Desai N. Switching from depot antipsychotics to risperidone: results of a study of chronic schizophrenia. Adv Ther 1999; 16: 78-88. (Pubitemid 29244958)
34. Hoencamp E, Knegtering H, Kooy US, van Der Molen AEGM. Patient requests and attitude towards neuroleptics. Nord J Psychiatry 1995; 49 (suppl 35): 47-55.
35. Eastwood N, Pugh R. Long-term medication in depot clinics and patients' rights: an issue for assertive outreach. Psychiatr Bull 1997; 21: 273-275 (Pubitemid 27224140)
36. Jacobsson L, Odling H. Psykologiska aspekter pa depabehandling vid schizofrena syndrom. Lakartidningen 1980; 77: 3522-3526
37. Wistedt B. How does the psychiatric patient feel about depot treatment, compulsion or help? Nord J Psychiatry 1995; 49 (suppl 35): 41-46